Browse studies
Find your next paid study
5 recruiting studies matching your filters
Phase 2
An Exploratory, Pilot, Single-site Study to Evaluate the Effect of QLS-111 Ophthalmic Solution on Posterior Perfusion and Vessel Dilation
Pilot, single-site, prospective study of QLS-111 0.015 % in subjects with NPDR, OAG or NTG
Non-proliferative Diabetic Retinopathy (NPDR)Open-angle Glaucoma (OAG)Normal Tension Glaucoma (NTG)
Estimated
~$10 – $8,750
Qlaris Bio, Inc.NCT07354477
Phase 4
Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use
The objective of this study is to evaluate whether reduction in topical medication with the injection of a sustained release capsule (Durysta) leads to a reduc…
GlaucomaOpen-Angle GlaucomaOcular Hypertension+1 more
Estimated
~$10 – $6,250
University of MiamiNCT07217678
Real-World Efficacy of Hydrus Microstent With OMNI Surgical System in Combination With Phacoemulsification: a Retrospective Analysis
Real-World efficacy of Hydrus Microstent with OMNI Surgical System in combination with Phacoemulsification: a retrospective analysis
Open-Angle Glaucoma
Estimated
~$10 – $1,125
Barnet Dulaney Perkins Eye CentersNCT06953349
Observational
A Randomized Controlled Trial Comparing Direct Selective Laser Trabeculoplasty (DSLT) and Selective Laser Trabeculoplasty (SLT) in Reducing Intraocular Pressure in Open-Angle Glaucoma
This study compares two FDA-approved laser treatments for glaucoma: Direct Selective Laser Trabeculoplasty (DSLT) and Selective Laser Trabeculoplasty (SLT). Bo…
Open-angle Glaucoma (OAG)Ocular Hypertension (OHT)
Estimated
~$10 – $6,250
Medical University of South CarolinaNCT07408154
Phase 1
A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint Comparing Generic Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® (Bimatoprost Ophthalmic Solution) 0.01% in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes
A randomized, double-blind, parallel-group, two-arm, multiple dose, multicenter, clinical endpoint bioequivalence study
Open-angle GlaucomaOcular Hypertension
Estimated
~$10 – $8,750
Amneal Pharmaceuticals, LLCNCT06267274